| Bioactivity | SARS-CoV-2-IN-46 is a novel coronavirus (SARS-CoV-2) replication inhibitor with an EC50 of 0.9 μM in Calu-3 cells. SARS-CoV-2-IN-46 has antiviral activity and can be used in novel coronavirus (COVID-19) research[1]. |
| Invitro | SARS-CoV-2-IN-46 (Compound 8w) (1-10 μm) 可在 Calu-3 细胞中抑制 SARS-CoV-2 复制 50% 以上[1]。SARS-CoV-2-IN-46 (Compound 8w) (250 μm; 72 h) 在 Calu-3 细胞中显示出低毒性[1]。 |
| Name | SARS-CoV-2-IN-46 |
| Formula | C17H12F2O4 |
| Molar Mass | 318.27 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Caleffi GS, et al. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication. J Nat Prod. 2023 Jun 23;86(6):1536-1549. |